While the concept of immunometabolism was termed merely 10 years ago, initial evidence dates back to the early 1990s, when increased expression of the pro-inflammatory cytokine tumor necrosis factor α (TNFα) was observed in rodent models of obesity and was shown to contribute to the development of insulin resistance (5). Here, TNF is linked to obesity disorder.